Abstract
A 10-year-old girl presented with a cerebral malignant ectomesenchymoma (MEM), a very unusual tumour with undifferentiated mesenchymal as well as ectodermal elements. Somatostatin receptor scintigraphy (SRS) was performed during the diagnostic workup. The recurrent residual tumour mass was exactly visualized with SRS, and was negative after successful treatment of the patient. The potential application of SRS in initial staging, follow-up and therapy planning in MEM is discussed. This is the first application of SRS in MEM.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 14 May 1999 Accepted: 8 May 2000
Rights and permissions
About this article
Cite this article
Papós, M., Pekrun, A., Herms, J. et al. Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report. Pediatric Radiology 31, 169–172 (2001). https://doi.org/10.1007/s002470000404
Issue Date:
DOI: https://doi.org/10.1007/s002470000404